Skip to main content
Log in

Evaluation of a Programming Algorithm for the Third Tachycardia Zone in a Fourth-Generation Implantable Cardioverter-Defibrillator

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

The clinical efficacy of electrical algorithms for termination of slowventricular tachycardia (VT) and ventricular fibrillation (VF) inimplantable cardioverter-defibrillators (ICDs) is well established. Suchalgorithms have not been equally well defined for fast VT reversion. Wereport the testing of a prospectively designed algorithm for ICDs to treatfast VT that is inherently less responsive to antitachycardia pacing thanslow VT. Fourth-generation ICD devices were programmed to threeprospectively defined tachycardia detection zones as follows: cyclelengths≤ ms for VF, 270-330 ms for fast VT, and >330 ms for slow VT.The initial selected therapy for the VF zone was a high-energy biphasicshock (>15J), while a 3- or 5-J biphasic shock was usually administered forfast VT, and antitachycardia pacing was initially attempted for slow VT.Initial therapy was followed by backup therapy with high-energy shocks.Twenty-eight patients, 24 of whom were males, all with organic heartdisease, with a mean age of 65 ± 9 years, received either a Medtronic7219D (23 patients), 7219C (2 patients), 7218SP1 (2 patients), or 7218C (1patient) ICD with a nonthoracotomy lead system. The defibrillation thresholdwas 10 ± 5 J. At predischarge electrophysiologic testing, a single 3-or 5-J shock terminated all episodes of fast VT tested. During a follow-upof 18 ± 9 months, there were four nonarrhythmic deaths. Fourteenpatients (50%) had a total of 21 VF, 44 fast VT, and 202 slow VTepisodes. Twenty-three of 24 (96%) VF, 33 of 39 (84%) fast VT,and 193 of 202 (95.5%) slow VT episodes were terminated with thefirst delivered therapy in each therapy algorithm (p=NS). The overallefficacy of the entire electrical therapy algorithm was 100% for VF,100% for fast VT, and 98% for slow VT episodes (p=NS).No patient experienced syncope or presyncope during fast VT or VF in thisstudy. We conclude that a third detection and therapy zone can besuccessfully programmed in ICDs to define a range of fast VT episodes thatcan be effectively terminated with lower energy cardioversion shocks withcomparable success and freedom from arrhythmic symptoms to electricaltherapies used for slow VT and VF..

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Mirowski M, Reid PR, Watkins L, et al. Clinical treatment of life-threatening ventricular tachyarrhythmias with the automatic implantable defibrillator. Am Heart J 1981;102:265–270.

    Google Scholar 

  2. Saksena S, Poczobutt-Johanos M, Castle LW, et al. for the Guardian Multicenter Investigators Group. Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. J Am Coll Cardiol 1992;19:490–499.

    Google Scholar 

  3. Saksena, S. The PCD Investigator Group. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable cardioverter-defibrillator implanted with or without thoracotomy: An international multicenter study. J Am Coll Cardiol 1994;23:1521–1530.

    Google Scholar 

  4. Saksena S, Krol RB, Kaushik RR. Innovations in pulse generator and lead systems: Balancing complexity with clinical benefit and long-term results. Am Heart J 1994;127(Suppl): 1010–1021.

    Google Scholar 

  5. Jung W, Manz M, Luderitz B. New technology for implantable cardioverter-defibrillators: Capacitors, lead systems, shock waveforms. In: Saksena S, Luderitz B, eds. Interventional Electrophysiology 1996, 2nd ed. Armonk, NY: Futura, 1996:257–281.

    Google Scholar 

  6. Saksena S, Prakash A. Implantable cardioverter-defibrillators: Clinical results and patient selection. In: Saksena S, Luderitz B, eds. Interventional Electrophysiology 1996, 2nd ed. Armonk, NY: Futura, 1996:283–304.

    Google Scholar 

  7. Wyse DG, Kavanagh KM, Gillis AM. Comparison of biphasic and monophasic shocks for defibrillation using a nonthoracotomy system. Am J Cardiol 1993;71:197–202.

    Google Scholar 

  8. Swerdlow CD, Chen PS, Kass RM, et al. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol 1994;23:1342–1355.

    Google Scholar 

  9. Gillberg JM, Olson WH, Bardy GH, et al. Electrogram width algorithm for discrimination of supraventricular rhythm from ventricular tachycardia (abstr). PACE 1994;17:866.

    Google Scholar 

  10. Lavergne T, Henry C, Ollitrault J, et al. Initial clinical experience with the first dual-chamber implantable cardioverter-defibrillator (abstr). PACE 1996;19:656.

    Google Scholar 

  11. Saksena S, Chandran P, Shah Y, et al. Comparative efficacy of transvenous cardioversion and pacing in patients with sustained ventricular tachycardia: A prospective, randomized, crossover study. Circulation 1985;72:153–160.

    Google Scholar 

  12. Bardy G, Poole J, Kudenchuk PJ, et al. A prospective randomized repeat crossover comparison of antitachycardia pacing with low energy cardioversion. Circulation 1993;87:1889–1896.

    Google Scholar 

  13. Saksena S, Luceri R, Krol RB, et al. Endocardial pacing, cardioversion and defibrillation using a braided endocardial lead system. Am J Cardiol 1993;71:834–841.

    Google Scholar 

  14. Saksena S, An H, Mehra R, et al. Prospective comparison of biphasic and monophasic shocks for implantable cardioverter-defibrillators using endocardial leads. Am J Cardiol 1992;70:304–310.

    Google Scholar 

  15. Fisher JD, Mehra R, Furman S. Termination of ventricular tachycardia with bursts of rapid ventricular pacing. Am J Cardiol 1978;41:94–102.

    Google Scholar 

  16. den Dulk K, Kersschot IE, Brugada P, et al. Is there a universal antitachycardia pacing mode? Am J Cardiol 1986;57:950–955.

    Google Scholar 

  17. Calvo RA, Saksena S, Pantopoulos D. Sequential transvenous pacing and shock therapy for termination of sustained ventricular tachycardia. Am Heart J 1988;115:569–575.

    Google Scholar 

  18. Ciccone JM, Saksena S, Shah Y, et al. A prospective randomized study of the clinical efficacy and safety of transvenous cardioversion for ventricular tachycardia termination. Circulation 1985;1:571–578.

    Google Scholar 

  19. Nathan AW, Bexton RS, Spurrell RA, et al. Internal transvenous low energy cardioversion for the treatment of cardiac arrhythmias. Br Heart J 1984;52:377–384.

    Google Scholar 

  20. Krol RB, Saksena S. Clinical trials of antiarrhythmic drugs in recipients of implantable cardioverter-defibrillators. In: Saksena S, Luderitz B, eds. Interventional Electrophysiology 1996, 2nd ed. Armonk, NY: Futura, 1996:365–375.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Neglia, J.J., Krol, R.B., Giorgberidze, I.S. et al. Evaluation of a Programming Algorithm for the Third Tachycardia Zone in a Fourth-Generation Implantable Cardioverter-Defibrillator. J Interv Card Electrophysiol 1, 49–56 (1997). https://doi.org/10.1023/A:1009766718942

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009766718942

Navigation